MARTA FENOLL MORANTE

Mrs. MARTA FENOLL MORANTE

Universidad de Castilla-La Mancha, Cuenca, Spain
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
CPCarlos Pascual-Morena
Carlos Pascual-Morena
IOIris Otero-Luis
Iris Otero-Luis
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
MMMARTA FENOLL MORANTE
MARTA FENOLL MORANTE
Background/Objectives: Age is a known predictor of skin autofluorescence (SAF) across populations, but age-based reference values are lacking for the Spanish population. This study aims to establish SAF reference values for healthy Spanish adults by age group, compare these with other populations, and estimate optimal SAF cut-off points by age range. Additionally, it aims to analyse the influence of sex, smoking, and skin phototype. Methods: This cross-sectional EVasCu study included 390 healthy subjects aged over 18 years. Participants’ age, sex, smoking status, and skin were recorded and categorised into age groups. Advanced glycation end products were measured through the SAF. A systematic review and meta-analysis, including an EVasCu study, was performed to obtain pooled means and standard deviations by age group. Results: The mean SAF Spanish values by age were (95% CI): (i) 18–19 years: 1.34–1.56 arbitrary units (AU); (ii) 20–29 years: 1.56–1.70 AU; (iii) 30–39 years: 1.66–1.84 AU; (iv) 40–49 years: 1.79–1.91 AU; (v) 50–59 years: 2.07–2.21 AU; (vi) ≥60 years: 2.07–2.50 AU. SAF was significantly correlated with age (r = 0.531; p < 0.001), smoking status (r = −0.196; p < 0.001), and skin phototype (r = 0.138; p = 0.007), and SAF was greater in smokers and dark-skinned individuals (p < 0.05). No significant differences were found in the SAF values for sex. The results of the meta-analysis were in line with those of the present study, providing reference values of SAF for the general population. Conclusions: SAF increases linearly with age in healthy individuals, and higher levels of SAF are observed in smokers and dark-skinned individuals.

24 December 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
ERElena Rescalvo-Fernández
Elena Rescalvo-Fernández
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
MMMaría Medrano
María Medrano
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
ASAlicia Saz-Lara
Alicia Saz-Lara
Objectives: This study aimed to examine the association between the visceral adiposity index and arterial stiffness in healthy adults via original data from the EVasCu study and to contextualize these findings through a meta-analysis of previously published studies in the general population. Methods: A cross-sectional analysis was conducted in 389 healthy adults from the EVasCu study. The visceral adiposity index was calculated on the basis of waist circumference, body mass index, triglycerides, and high-density lipoprotein cholesterol, integrating the anthropometric and metabolic components of visceral adiposity. Arterial stiffness was assessed by the aortic pulse wave velocity. These original findings were complemented by a meta-analysis, including EVasCu data and data from prior studies, to obtain pooled correlation coefficients and 95% confidence intervals (CIs) for the association between visceral adiposity and arterial stiffness. Results: In the EVasCu study, the visceral adiposity index showed a statistically significant moderate correlation with the aortic pulse wave velocity (r = 0.281, p < 0.001). In the meta-analysis, the pooled correlation coefficient was 0.34 (95% CI: 0.27, 0.42), supporting a consistent association between the visceral adiposity index and both central and peripheral arterial stiffness across diverse populations. Conclusions: These findings indicate a positive association between the visceral adiposity index and arterial stiffness in both healthy individuals and populations with cardiometabolic conditions. However, given the predominantly cross-sectional nature of the evidence and the heterogeneity among the included studies, the results should be interpreted with caution. Further longitudinal, multivariable, and mechanistic studies are needed to clarify the clinical relevance of the visceral adiposity index beyond correlation and to determine its potential role as a complementary marker in cardiovascular risk assessment.

22 October 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
IOIris Otero-Luis
Iris Otero-Luis
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
MMMARTA FENOLL MORANTE
MARTA FENOLL MORANTE
ASAlicia Saz-Lara
Alicia Saz-Lara
(1) Background: Heart failure with preserved ejection fraction (HFpEF) is a clinical challenge, with limited success from current therapeutic strategies. This study aimed to assess the impact of combined exercise (CE) and high-intensity interval training (HIIT) on key biomechanical parameters during the 6-minute walk test (6MWT) in HFpEF patients. (2) Methods: A randomized controlled trial was conducted in 76 sedentary HFpEF patients, divided into three groups as follows: the CE, HIIT, and control groups. CE involves aerobic and strength training, whereas HIIT includes high-intensity intervals. Cadence (steps per minute), distance, maximum heart rate (HRmax), and exercise intensity were measured pre- and postintervention. (3) Results: The results revealed significant improvements in cadence in the CE group compared with the control group (p = 0.009) for intention-to-treat analysis, and in the control and HIIT groups (p = 0.002) for per-protocol analysis. CE also significantly improved HRmax and exercise intensity, suggesting an enhanced cardiovascular response. In contrast, HIIT did not significantly affect these parameters. The correlation between cadence and distance covered during the 6MWT was strong in the overall group (r = 0.762, p < 0.001). (4) Conclusions: These findings suggest that CE is an effective intervention to improve gait efficiency, cardiovascular response, and functional capacity in HFpEF patients, whereas HIIT may require further investigation in this population.
1

15 April 2025 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
MMMARTA FENOLL MORANTE
MARTA FENOLL MORANTE
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
IOIris Otero-Luis
Iris Otero-Luis
ASAlicia Saz-Lara
Alicia Saz-Lara

Verified
Journal Article
Open access
PDF file
MMMARTA FENOLL MORANTE
MARTA FENOLL MORANTE
ASAlicia Saz-Lara
Alicia Saz-Lara
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
IOIris Otero-Luis
Iris Otero-Luis
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Background. Cardiometabolic diseases are the leading cause of morbidity and mortality worldwide and are driven by risk factors such as hypertension, diabetes mellitus, and dyslipidemia. Early vascular aging (EVA) is a pathological process characterized by accelerated arterial stiffness and endothelial dysfunction, which increase the risk of cardiovascular events. Key markers of EVA include advanced glycation end products (AGEs), aortic pulse wave velocity (a-PWV), glycated hemoglobin A1c (HbA1c) and pulse pressure (PP). Although these markers are individually associated with cardiovascular outcomes, there is still limited evidence from longitudinal studies evaluating their combined association with cardiometabolic diseases and hypertension, particularly with consideration of gender differences. Therefore, in this study, data from the two-year EVasCu cohort were used to analyze the associations between EVA and cardiometabolic diseases and hypertension; the associations between EVA related parameters (AGEs, a-PWV, HbA1c and PP) were evaluated, and these associations were assessed by gender. Methods. AGE, a-PWV, HbA1c and PP were measured as indicators of EVA, in addition to sociodemographic and clinical variables. Logistic regression was applied to assess the association between EVA and cardiometabolic diseases (including hypertension, diabetes mellitus, acute myocardial infarction (AMI), dyslipidemia, angina pectoris, and heart failure (HF)) and hypertension, adjusting for age, gender and risk factors. Results. A 2-year longitudinal study was conducted with 200 adults in Cuenca, Spain. EVA was significantly associated with the development of cardiometabolic diseases (OR = 1.38; p = 0.028) and hypertension (OR = 1.63; p = 0.015), which was more pronounced in females. Cardiometabolic diseases and hypertension were associated with a-PWV and PP, but not with AGEs or HbA1c. Conclusions. a-PWV and PP are predictors of cardiometabolic diseases and hypertension, especially in females. Early detection and preventive strategies are essential for detecting cardiovascular risk and mitigating consequences. Further studies are needed to investigate the relationships between EVA and cardiometabolic factors.

13 October 2026 in Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
MMMARTA FENOLL MORANTE
MARTA FENOLL MORANTE
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
NFNadia Fenoll-Morante
Nadia Fenoll-Morante
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
ASAlicia Saz-Lara
Alicia Saz-Lara
Background: Early vascular aging (EVA) is associated with increased cardiovascular risk and poor health-related quality of life. The extent to which EVA affects the physical and mental components of quality of life across different age groups remains insufficiently described. Objective: We aimed to analyze the associations between EVA and the physical and mental components of quality of life and examine global associations and age-stratified differences. Methods: A total of 583 participants from the EVasCu and VascuNet cohorts were analyzed. EVA was defined as a construct integrating 4 parameters (aortic pulse wave velocity, a-PWV; pulse pressure; glycosylated hemoglobin A1c, HbA1c; and advanced glycation end products, AGEs). Distance to healthy vascular aging (HVA) and the EVA/HVA ratio were computed. Health-related quality of life was assessed using the 12-item short form health survey. Results: Physical quality of life was negatively correlated with EVA risk (r = −0.209; P = .001) and the distance to HVA (r = –0.240; P < .001) and positively correlated with the EVA/HVA ratio (r = 0.168; P < .001). Mental quality of life was negatively correlated with the EVA/HVA ratio (r = –0.095; P = .022). Significant differences in physical quality of life were found by EVA/HVA ratio in people aged 25–60 ( P = .008) and >60 ( P = .036). Conclusions: Vascular deterioration is related to physical health and perceived emotional well-being, reinforcing the usefulness of the EVA model as a comprehensive marker of vascular aging. These findings suggest that individuals’ perceptions of their physical and mental health are closely associated with EVA risk.